Antimicrobial susceptibility of Branhamella catarrhalis isolates from bronchopulmonary infections.
Fifty-four clinical isolates of Branhamella catarrhalis from patients with bronchopulmonary infections were studied. The MICs for 50 and 90% of the isolates and the geometric mean MICs were determined for 11 antimicrobial agents. All the strains were resistant to trimethoprim but were susceptible to clavulanate-potentiated amoxicillin (Augmentin; Beecham Research Laboratories, London), chloramphenicol, co-trimoxazole, erythromycin, cefotaxime, and cefuroxime. Beta-lactamase-negative strains were uniformly susceptible to penicillin and ampicillin.
D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D001424:Bacterial Infections / Q000382:microbiology*; D006801:Humans; D008171:Lung Diseases / Q000382:microbiology*; D008826:Microbial Sensitivity Tests; D009346:Neisseriaceae / Q000187:drug effects*
D000900:Anti-Bacterial Agents